Same asset, new use: management describes redeploying something the company already owns into a materially higher-value
The model's full reasoning — Q3 2018 call → NOWe need answer YES or NO based on transcript. Need determine if management describes currently putting something it already owns/does to different and materially more valuable use than originally intended, with real activity. Let's parse transcript. Company Precipio. They have ICP technology (ICE-COLD PCR) originally developed? They launched tests. They have pathology services. They developed IV-Cell and HemeScreen. Need see if any existing asset redirected to new purpose with better economics and already in motion. Key candidates: Pathology services as platform for developing technologies? They say pathology services side serves not only revenue generator but also marketing and testing platform for new technologies. But that's using existing lab to develop/validate technologies. Is that a change of purpose? The lab was originally for diagnostics, now also used to develop and test new technologies. But is that materially more valuable? They say technologies created internally in CLIA lab receiving specimens, gained access to challenges, R&D team came up with solutions. This is using lab workflow to develop products. But is that "different and materially more valuable use" than original? Not exactly; it's an additional benefit, not redirecting asset to new purpose with better economics. They still do pathology services. Another: HemeScreen born from frustrations of existing test used in CLIA lab. They developed new proprietary alternative, tested internally, launched internally, now begun to commercialize externally. This is a new technology developed, not existing asset redirected? It's a new product created from R&D. Not "already owns" thing being redirected? It is a new technology, not previously used for something else. So no. IV-Cell: proprietary cytogenetics media. They developed it. It was created internally. They are commercializing. Not redirecting existing asset. ICP: They have technology, expanded panels. Perkin Elmer collaboration: Perkin selected ICP as complementary enrichment technology. This is licensing/co-marketing existing technology to partner. Is that a change of purpose? ICP was originally developed for their own tests? Now they are selling/partnering to enable others. That could be redirecting technology from internal use to external sales.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| SANG | Sangoma Technologies Corporation | Q2 2024 | 2024-02-08 | D |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| GGR | Gogoro Inc. | Q1 2023 | 2023-05-11 | D |
APPS · Q1 2024 → YESThe question is whether management describes currently putting something they already own or do to a different and materially more valuable use, and that this is already happening now. YES Bill Stone describes using the company’s existing on-device technology and installed base of hundreds of millions of devices (already owned and paid for) for a new purpose: alternative app distribution via DT Hub and SingleTap monetization. He states they have launched DT Hub with four U.S. operators and are generating revenue today with incremental higher RPDs from devices engaging with the Hub product, and they are leveraging existing hub capabilities to enable direct distribution outside Apple/Google stores. This is presented as already happening now, with the new use delivering better economics through higher RPD accretion and expanded revenue streams.
PRPH · Q1 2023 → YESThe question is whether management describes currently putting something they already own or do to a different and materially more valuable use, and that this change is already happening now. YES The transcript shows management describing a clear redirection of assets already owned: the manufacturing facility (originally kept solely for Cold-EEZE infrastructure after the brand sale) is now being run for third-party lozenge manufacturing, with revenues growing nearly 100% year-over-year and $25 million targeted for 2024 — a use they explicitly call “the least interesting business” yet one with “enormous value” and an estimated $70 million next-year market value.
GGR · Q1 2023 → YESThe question is about whether Gogoro is currently putting something it already owns or does to a different and materially more valuable use. YES The transcript shows Gogoro is already redirecting its existing battery-swapping network and smart batteries (originally built for vehicle swaps) into a new Virtual Power Plant use case via the Enel X partnership.